Mellis is vice president, early clinical development and experimental sciences, rare diseases, with Regeneron Pharmaceuticals Inc., a biopharmaceutical company that develops and commercializes new medicines. He served as medical director of Pfizer Pharmaceuticals before joining Regeneron in 2001 and is now leading an effort to optimize Regeneron's development of new medications for patients with rare diseases.